Recent shortages have frustrated patients, proving that logistics are as critical as innovation
In many ways, Wegovy is simply a higher-dose version of Ozempic, as they both contain the same active ingredient
dulaglutide (1.5 mg weekly) for both non-inferiority and superiority in terms of CV outcomes ( 3.4 Effects on heart failure In addition to their demonstrated CV benefits, GLP-1 RAs have showed promising signals for their potential benefits in HF management
Adapt Adjust the plan as results, recovery, medications, injuries, and real-life demands change
The modality is novel enough that if Phase 1 PK/PD confirms durable receptor coverage, it will open an entirely new format vector for incretin drug development
They bind to GLP-1 ra receptors, lowering blood glucose and A1C levels and causing delayed gastric emptying, which can decrease appetite